NFE2L2 and cancer: The anchorage-independent survival of cancer cells described above is supported primarily by glutamine catabolism via the adenosine 5’-monophosphate (AMP)-activated protein kinase (AMPK)/nuclear factor erythroid 2-related factor 2 (Nrf2) signaling axis.